Search results
Case Discussions: STEMI & LM Bifurcation Stenting
Author(s):
Bill D Gogas
,
Syed Tanveer Rab
Added:
3 years ago
Video Series
Author(s):
Ali Nazmi Calik
,
F Aaysha Cader
,
Erik Rafflenbeul
,
et al
Added:
8 months ago
Author(s):
Charalampos Varlamos
,
Ioannis Lianos
,
Despoina-Rafailia Benetou
,
et al
Added:
2 years ago
Author(s):
Niels Ramsing Holm
Added:
7 months ago
ESC 2023 — Dr Niels Ramsing Holm (Aarhus University, DK) outlines the findings from the OCTOBER trial (NCT03171311).
The OCTOBER trial (Aarhus University Hospital Skejby, Abbott) aimed to compare the median two-year clinical outcome after optical coherence tomography (OCT) guided percutaneous coronary intervention (PCI) as compared to angiographic-guided PCI. This was an investigator-initiated…
View more
Author(s):
José M de la Torre Hernández
,
Hee Hwa Ho
,
,
et al
Added:
2 years ago
Left Main Coronary Artery (LMCA) intervention is challengingto the operator due to a wide array of factors as compared to treating other stenosis elsewhere in the coronary tree. Complications arising from hemodynamic instability, lack of proximal reference angiographically and lesion preparation due to a higher rate of atherosclerosis make LM Coronary Artery Disease (CAD) by far the most complex…
View more
Proximal Side Optimization
Author(s):
Francesco Lavarra
Added:
3 years ago
Article
EuroPCR 2023: Late-Breaking Science Video Collection
Author(s):
D Scott Lim
,
Sandeep Arunothayaraj
,
Paul Sorajja
Added:
11 months ago
Video Series
Author(s):
Abdulrahman Almoghairi
,
Nayef Al-Asiri
,
Khalid Al Johani
,
et al
Added:
9 months ago
Justin E Davies
Author
Author(s):
Mirvat Alasnag
Added:
11 months ago
EuroPCR 23 — We are joined by Dr Mirvat Alasnag (The King Fahd Armed Forces Hospital, SA) for an insightful summary of three late-breaking trials that are expected to have a impact on interventional science and clinical practice.
Trials covered in detail include:
EBC TWO Five Year Follow-Up: Two-Stent Vs One for Large Bifurcation Lesions
BASILICA Vs Chimney-Stenting for TAVR-Related Coronary…
View more